While loss of BRM/BRG1 is associated with clinical poor prognosis in non-small cell lung cancers [48], many others have suggested that elevated BRM/BRG1 levels is a prognostic factor for various types of cancers [49,50,51]. This evidence concerns the gene SMARCA2 and cancer.